Product Information
HYZAAR 100-12.5 TABLET is a brand product labeled by Organon LLC, priced at $6.8200 per EA under NDC 78206014001. Its NADAC has been published 110 times since May 22, 2024.
The High Outlier badge above means this manufacturer's average price in the losartan potassium and hydrochlorothiazide market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
12.5; 100 mg/1; mg/1
Manufacturer
Organon LLCNDC
78206014001
Classification
Brand
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
1/1/2026
Active Ingredients
HYDROCHLOROTHIAZIDE; LOSARTAN POTASSIUMApproval Type
New Drug (NDA)
FDA Application
NDA020387On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for HYZAAR 100-12.5 TABLET has been published 110 times since May 22, 2024, and over the history we have for it it has risen 10.4%. The table below summarizes its recorded NADAC range and movement.
| Current price | $6.8200 per EA |
|---|---|
| All-time high | $6.8200 (Jun 24, 2026) |
| All-time low | $6.1589 (Sep 18, 2024) |
| 52-week high | $6.8200 |
| 52-week low | $6.4736 |
| Median price | $6.4736 |
| Average price | $6.4686 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 110 |
| Tracking since | May 22, 2024 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of HYZAAR 100-12.5 TABLET?
The current National Average Drug Acquisition Cost (NADAC) for HYZAAR 100-12.5 TABLET, manufactured by Organon LLC, is $6.8200 per EA (NDC 78206014001), effective Jun 24, 2026.
How has the price of HYZAAR 100-12.5 TABLET changed over time?
Over the history we have for it, the NADAC for HYZAAR 100-12.5 TABLET has risen 10.4%. It has been tracked across 110 weekly CMS publications since May 22, 2024.
What are the highest and lowest recorded NADAC prices for HYZAAR 100-12.5 TABLET?
Since May 22, 2024, the NADAC for HYZAAR 100-12.5 TABLET has ranged from a low of $6.1589 (Sep 18, 2024) to a high of $6.8200 (Jun 24, 2026), with a median of $6.4736 per EA.
Are there cheaper alternatives to HYZAAR 100-12.5 TABLET?
Yes. 4 NADAC-published products share the same active ingredient, strength, and dosage form. The lowest-priced option, LOSARTAN-HYDROCHLOROTHIAZIDE 100-12.5 MG TAB, is $0.0754 per EA — about 99% below HYZAAR 100-12.5 TABLET.
Who manufactures HYZAAR 100-12.5 TABLET?
HYZAAR 100-12.5 TABLET (NDC 78206014001) is labeled by Organon LLC, and CMS classifies it as a brand product.
Related Drugs
Same classification